AbbVie Inc. (ABBV)

About AbbVie Inc.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

As of November 3, 2026, AbbVie Inc. (ABBV) stock edged higher to $289.78, up 0.33% (+$0.94) versus the previous close. On the day, shares have traded between $286.91 and $291.32. That puts ABBV near the top of its 52-week range of $190.75 to $298.74. AbbVie Inc. operates in the pharmaceutical preparations space and carries a market capitalization of roughly $521.11 billion, with about 335.7K shares changing hands.

Latest ABBV news

• What Could Derail Bristol Myers Squibb Stock?trefis.com· Nov 3, 9:12 AM ET
• Lilly’s R&D whirlwind — what the large pharma has taken in and what it’s droppedpharmavoice.com· Nov 3, 8:48 AM ET
• Allergan Aesthetics to Present New Research on Aesthetic Care Following Medical Weight Loss and Evolving Patient Needs at ASDS 2026Yahoo Finance· Nov 3, 8:00 AM ETASDS
• Sector Update: Healthcare Stocks Ease Late AfternoonYahoo Finance· Nov 2, 3:58 PM ET
• ABBV Q3 deep dive: Immunology and neuroscience drive growth, pipeline progress continuesYahoo Finance· Nov 2, 2:57 PM ET
• AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology TransitionYahoo Finance· Nov 2, 12:49 PM ET
• The Best Dividend Stocks to Buy With $5,000 in Novemberfool.com· Nov 2, 12:35 PM ET
• AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy for 2027?fool.com· Nov 2, 11:20 AM ET

Source: Yahoo Finance RSS · Updated November 3, 2026

Want ABBV headlines, alerts and AI research in one place? Create a free account →

• $ABBV Share Price: $288.75 Contract Selected: Nov 27, 2026 $290 Calls Buy Zone: $6.54 – $8.09 Target Zone: $11.47 – $14.02 Potential Upside: 65% ROI Time to Expiration: 24 Days | Updates via https://fxcapta.com/stockinfo/

  @SuperGreenToday· Nov 2, 8:36 PM ET

• $ABBV is up 11% since Oct 5, when its Quality Score reached 20. Shares are up 27% over the past year. getbreakaway.com/ABBV

  @BigAllergies· Nov 2, 6:41 PM ET

• $ABBV "Michael J. Fox’s promotion to Companion of the Order of Canada on October 2, 2026, recognized a remarkable transformation: a celebrated actor had become one of the world’s most consequential advocates for Parkinson’s research. His foundation, established in 2000, h…

  @jheerdink· Nov 2, 5:28 PM ET· Bullish

• #Biotechnology #Stocks Break Out To Leadership Position With Growth Mentions: $ABBV $GILD $LLY $MRK $IBB https://talkmarkets.com/article/biotechnology-stocks-break-out-to-leadership-position-with-growth

  @TalkMarkets· Nov 2, 3:16 PM ET

• $ABBV Long term: bullish, short term: ???

  @DignitaryFinancial· Nov 2, 2:59 PM ET· Bullish

Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →